Company: CWAN
Filing Date: 2025-02-11
Form Type: S-4
Source: 0001193125-25-023759
Chunk: 22

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-02-11
Form: S-4
Chunk 22
---
| A: | You are being asked to vote upon the following proposals: |

| 1. | Proposal 1—The Merger Agreement Proposal: the proposal to adopt the Merger Agreement, which                                                                                                                      
 is further described in the sections titled “The Transactions” and “The Merger Agreement” and a copy of which is attached to this Proxy Statement/Prospectus as Annex A, and to approve the Mergers (the “Merger 
 Agreement Proposal”); and                                                                                                                                                                                        |

| 2. | Proposal 2—The Adjournment Proposal: the proposal to approve the adjournment of the Special                                                                   
 Meeting, if necessary, to solicit additional proxies if there are not sufficient votes to approve the Merger Agreement Proposal (the “Adjournment Proposal”). |

| Q: | How does the Enfusion Board of Directors recommend that I vote at the Special Meeting? |

| A: | The board of directors of Enfusion (the “Enfusion Board”) unanimously recommends that Enfusion 
 Stockholders vote “FOR” the Merger Agreement Proposal and “FOR” the Adjournment Proposal.      |

| Q: | What do I need to do now? |

| A: | After carefully reading and considering the information contained in this Proxy Statement/Prospectus, please                                                                                                                                   
 submit your proxy as soon as possible so that your shares of Enfusion Common Stock or Enfusion Class B Common Stock will be represented and voted at the Special Meeting. Please follow the instructions set forth on the proxy card or on the 
 voting instruction card provided by the record holder if your shares are held in “street name” by your bank, brokerage firm or other nominee.                                                                                                  |

| Q: | When and where is the Special Meeting of the Enfusion Stockholders? |

| A: | The Special Meeting will be held on      , 2025, beginning at                                                                                                                                   
 a.m., Central time, unless postponed to a later date, via live audio webcast at    . You will need the    -digit control number provided on your proxy card or voting instruction card in order 
 to participate in the Special Meeting.                                                                                                                                                          |

| Q: | Who can vote at the Special Meeting? |

| A: | Only Enfusion Stockholders who held shares of record as of the close of business on                                                                                                                      
 , 2025, the record date for the Special Meeting, are entitled to receive notice